Ajust text size (less) Ajust text size (more)
Adjust text size
 

Guidelines


  • Guidelines: New hepatitis C medicines  (member only content)
    The following hepatitis C medicines are newly listed on the Pharmaceutical Benefits Scheme (PBS) from 1 March 2016.

    To see this content you need to log in.
     
  • Guidelines: HIV and community pharmacy  (member only content)
    From 1 July 2015 HIV medicines are able to be dispensed in community pharmacy, with Government remuneration. The medicines remain Section 100 Highly Specialised Drugs (S100) but will be accessible by patients from community pharmacies, where previously these medicines have only been dispensed in hospital settings. The PSA has produced comprehensive practice support resources that give community pharmacists a valuable overview of the changes, the condition and the medicines used in treatment: These resources were developed under contract from the Commonwealth Department of Health and in collaboration with a number of relevant stakeholders:
    • The Pharmacy Guild of Australia
    • The Society of Hospital Pharmacists of Australia
    • The Australasian Society of HIV Medicine (ASHM)
    • Representatives drawn from:
      • State and Territory Health Departments
      • HIV prescribers
      • HIV dispensing pharmacists
      • Community pharmacy owners
      • HIV nurses
      • HIV consumer health advocate organisations.


    To see this content you need to log in.
     
  • Guidelines: Sleep apnoea
    Picture of sleep apnoea machineThe Pharmaceutical Society of Australia, in conjunction with the Australasian Sleep Association, has developed Practice guidelines for the provision of sleep apnoea services within pharmacy.
     
  • Guidelines: Di-Gesic and Doloxene dispensing
    A document prepared by PSA and Aspen to fulfil the requirements set out through the Administrative Appeals Tribunal decision on 12 September 2013 in relation to the prescribing and dispensing of dextropropoxyphene- containing products.
     
  • Standard: Clinical interventions
    A clinical intervention is the process of identifying a drug related problem and making a recommendation in an attempt to prevent or resolve it.
     
  • Guidelines: Internet and social media use
    This document is designed to help pharmacists and consumers use the internet and social media to disseminate and receive information about health issues.
     
  • Guidelines: Immunisation services
    The Practice guidelines for the provision of immunisation services within pharmacy have been developed by the Pharmaceutical Society of Australia (PSA) for pharmacists and pharmacies involved in hosting immunisation services.
     
  • Guidelines: Continued dispensing
    Continued Dispensing is the supply of an eligible medicine to a consumer under the Pharmaceutical Benefits Scheme when there is an immediate need for that medicine but it is not practicable to obtain a prescription.
     
  • Guidelines: MedsCheck and Diabetes MedsCheck
    Photograph of MedscheckThe guidelines for pharmacists providing medicines use review (MedsCheck) and diabetes medication management (Diabetes MedsCheck) services have been developed by the Pharmaceutical Society of Australia for pharmacists under Fifth Community Pharmacy Agreement (5CPA) funding arrangements.
     
  • Guidelines: Home Medicines Reviews and Residential Medication Management Reviews
    Download practice guidelines for Home Medicines Review services, download practice guidelines for Home Medicines Review services, Residential Medication Management Review and Quality Use of Medicines services
     

our vision: Improving Australia's health through excellence in pharmacist care